首页 News 正文

Lilly plans to launch the obesity drug Telposide in India as early as next year

王俊杰2017
224 0 0

On February 28th, Eli Lilly CEO Dai Wenrui stated in an interview that the company expects to launch the obesity drug Tirzepatide in India as early as next year.
During his keynote speech at the BioAsia conference held in the state of Trengana, India, Dai Wenrui pointed out that India should strengthen patent protection, abolish redundant policies, and establish a social safety net to win more investment from global pharmaceutical companies. (Reuters)
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

王俊杰2017 注册会员
  • 粉丝

    0

  • 关注

    0

  • 主题

    28